Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Antiepileptic drugs can cause side effects like menstrual problems and infertility in women with epilepsy, but most pregnancies result in healthy babies, with newer drugs being safer.

Topical Valproate is safe for human skin and unlikely to cause irritation.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Scalp cooling therapy helped over 80% of women keep at least half their hair during chemotherapy.

Gefitinib can cause hair loss without scarring.

Etanercept may cause hair fragility and breakage.

Tofacitinib is effective and safe for treating alopecia areata.

A woman's adrenal tumor disappeared after treatment with cyproterone acetate.

Afatinib can cause eyelash and eyebrow issues, leading to eye irritation and pain.

Tapinarof cream at 1% concentration is effective and better tolerated for treating atopic dermatitis than the 2% concentration.

Diane is effective for treating acne, seborrhoea, androgenic alopecia, and mild hirsutism in women.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

Tirzepatide might help manage PCOS in obese patients but needs more research to confirm safety and effectiveness.

Using three different drugs together may better treat eye diseases like glaucoma and macular degeneration.

Titagen® improves skin, hair, nail health, and reduces osteoarthritis symptoms safely.

Ritlecitinib is more effective and cost-efficient than baricitinib for severe alopecia areata.

The cerium-polypeptide hydrogel effectively heals drug-resistant bacterial wounds by fighting bacteria, reducing inflammation, and promoting tissue repair.

Oral and topical tofacitinib can help regrow hair in people with severe alopecia areata.

Electric pulse treatments for breast cancer show promise in being safer and more effective, with fewer side effects.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Ritlecitinib is generally safe for adolescents with alopecia areata over 5 years.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

PROTACs show promise for cancer treatment, but designing them effectively is challenging.

Pulsed electric field treatment may help shrink untreated liver tumors.

Trametinib can cause skin issues, but they can often be managed without stopping the drug.

New treatment for hair loss using special microneedles shows promise in reducing inflammation and promoting hair growth.

TSC22D genes are key in metabolic diseases and cancer, offering potential as treatment targets.